[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100627147":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":19,"responsibleParty":84,"collaborators":7,"id":86,"slug":87,"hasResults":88,"nctId":89,"briefTitle":90,"officialTitle":90,"acronym":91,"eligibilityCriteria":92,"healthyVolunteers":88,"sex":93,"minAge":94,"maxAge":7,"enrollmentInfo":95,"targetDuration":98,"studyType":99,"phases":7,"briefSummary":100,"conditions":101,"keywords":103,"overallStatus":72,"whyStopped":7,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":106,"startDateStruct":109,"completionDateStruct":111,"leadSponsor":113,"locationsCount":114},{"fullName":5,"class":6},"University Hospital, Tours","OTHER",null,[9,15],{"name":10,"role":11,"phone":12,"phoneExt":13,"email":14},"Marco PASI, Pr","CONTACT","2.47.47.80.21","+33","m.pasi@chu-tours.fr",{"name":16,"role":11,"phone":17,"phoneExt":13,"email":18},"Sophie QUERAUD","247470156","s.queraud@chu-tours.fr",[20,40,55,70],{"facility":21,"status":22,"city":23,"state":7,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"university hospital, Angers","NOT_YET_RECRUITING","Angers","49000","France","FR",{"type":28,"coordinates":29},"Point",[30,31],-0.55202,47.47156,{"lat":31,"lon":30},[34,38],{"name":35,"role":11,"phone":36,"phoneExt":13,"email":37},"Sophie GODARD, Dr","241353591","sogodard@chu-angers.fr",{"name":35,"role":39,"phone":7,"phoneExt":7,"email":7},"PRINCIPAL_INVESTIGATOR",{"facility":41,"status":22,"city":42,"state":7,"zip":43,"country":25,"countryCode":26,"cosmosGeoPoint":44,"geoPoint":48,"contacts":49},"university hospital, Lille","Lille","59000",{"type":28,"coordinates":45},[46,47],3.05512,50.63391,{"lat":47,"lon":46},[50,54],{"name":51,"role":11,"phone":52,"phoneExt":13,"email":53},"Charlotte CORDONNIER, Pr","3.20.44.68.14","charlotte.cordonnier@chu-lille.fr",{"name":51,"role":39,"phone":7,"phoneExt":7,"email":7},{"facility":56,"status":22,"city":57,"state":7,"zip":58,"country":25,"countryCode":26,"cosmosGeoPoint":59,"geoPoint":63,"contacts":64},"University hospital, Toulouse","Toulouse","31000",{"type":28,"coordinates":60},[61,62],1.44367,43.60426,{"lat":62,"lon":61},[65,69],{"name":66,"role":11,"phone":67,"phoneExt":13,"email":68},"Nicolas RAPOSO, Pr","561779486","raposo.n@chu-toulouse.fr",{"name":66,"role":39,"phone":7,"phoneExt":7,"email":7},{"facility":71,"status":72,"city":73,"state":7,"zip":74,"country":25,"countryCode":26,"cosmosGeoPoint":75,"geoPoint":79,"contacts":80},"University hospital","RECRUITING","Tours","37000",{"type":28,"coordinates":76},[77,78],0.70398,47.39484,{"lat":78,"lon":77},[81,82,83],{"name":10,"role":11,"phone":12,"phoneExt":13,"email":14},{"name":16,"role":11,"phone":17,"phoneExt":13,"email":18},{"name":10,"role":39,"phone":7,"phoneExt":7,"email":7},{"type":85,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100627147","improving-the-prognosis-for-cerebral-hemorrhage-a-study-of-clinical-biological-and-imaging-markers-100627147",false,"NCT07444853","Improving the Prognosis for Cerebral Hemorrhage A Study of Clinical, Biological, and Imaging Markers","TIPITCH","Inclusion Criteria:\n\n* Age ≥ 18 years;\n* Emergency admission to a participating center, with spontaneous intracerebral hemorrhage confirmed by the first brain imaging (CT or MRI) performed at the time of initial treatment;\n* Obtaining non-opposition\n\nExclusion Criteria:\n\n* First brain imaging performed outside a center participating in the study (e.g., peripheral center not recruiting);\n* Intracerebral hemorrhage secondary to another identified condition, including:\n\n  * vascular malformation (aneurysm, arteriovenous malformation, cavernoma, etc.);\n  * intracranial tumor;\n  * hemorrhagic transformation of a cerebral infarction;\n  * recent head trauma.\n* Patient under legal protection;\n* Patient under guardianship or conservatorship.","ALL","18 Years",{"count":96,"type":97},10000,"ESTIMATED","2 Years","OBSERVATIONAL","This study will establish a prospective, multicenter national cohort of patients with spontaneous intracerebral hemorrhage (ICH). A standardized multimodal database integrating clinical, biological, and imaging data will be collected.\n\nThe study aims to better characterize ICH patient phenotypes, identify diagnostic and prognostic biomarkers, and describe adherence to evidence-based acute management strategies, including the proportion of patients managed according to the care bundle validated in the INTERACT 3 study.\n\nThe cohort is also intended to provide a structured platform for translational research and the preparation of future stratified interventional clinical trials in spontaneous ICH.",[102],"Intracerebral Hemorrhage (ICH)",[104],"diagnostic and prognostic biomarkers","2026-04-29",{"date":107,"type":108},"2026-05-06","ACTUAL",{"date":110,"type":108},"2026-04-09",{"date":112,"type":97},"2036-04",{"name":5,"class":6},4]